Colgate-Palmolive Company (NYSE:CL) has been given a consensus recommendation of “Hold” by the seventeen ratings firms that are presently covering the firm. One investment analyst has rated the stock with a sell recommendation, twelve have assigned a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $74.85.

Several research firms have recently weighed in on CL. Zacks Investment Research lowered shares of Colgate-Palmolive Company from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Wells Fargo & Company restated a “market perform” rating on shares of Colgate-Palmolive Company in a research report on Tuesday, November 15th. RBC Capital Markets set a $71.00 price objective on shares of Colgate-Palmolive Company and gave the company a “hold” rating in a research report on Monday, January 2nd. Barclays PLC restated a “hold” rating and set a $63.00 price objective on shares of Colgate-Palmolive Company in a research report on Tuesday. Finally, B. Riley restated a “neutral” rating and set a $78.00 price objective on shares of Colgate-Palmolive Company in a research report on Wednesday, November 2nd.

Colgate-Palmolive Company (NYSE:CL) opened at 65.88 on Wednesday. Colgate-Palmolive Company has a 12 month low of $61.40 and a 12 month high of $75.38. The company’s 50-day moving average is $65.97 and its 200 day moving average is $70.95. The firm has a market cap of $58.56 billion, a price-to-earnings ratio of 43.09 and a beta of 0.67.

Colgate-Palmolive Company (NYSE:CL) last announced its earnings results on Thursday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm earned $3.87 billion during the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive Company had a net margin of 8.96% and a return on equity of 6,924.14%. Colgate-Palmolive Company’s revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 EPS. On average, equities research analysts predict that Colgate-Palmolive Company will post $2.81 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 15th. Investors of record on Monday, January 23rd will be given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 2.37%. The ex-dividend date is Thursday, January 19th. Colgate-Palmolive Company’s payout ratio is presently 101.96%.

In other Colgate-Palmolive Company news, insider Jennifer Daniels sold 7,072 shares of the stock in a transaction that occurred on Tuesday, December 13th. The stock was sold at an average price of $66.78, for a total transaction of $472,268.16. Following the transaction, the insider now owns 37,463 shares in the company, valued at $2,501,779.14. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Patricia Verduin sold 3,834 shares of the stock in a transaction that occurred on Thursday, December 15th. The shares were sold at an average price of $65.66, for a total value of $251,740.44. Following the transaction, the insider now owns 54,791 shares in the company, valued at approximately $3,597,577.06. The disclosure for this sale can be found here. Corporate insiders own 1.05% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the stock. Quadrant Capital Group LLC increased its position in shares of Colgate-Palmolive Company by 200.6% in the third quarter. Quadrant Capital Group LLC now owns 1,485 shares of the company’s stock valued at $103,000 after buying an additional 991 shares during the period. Krilogy Financial LLC increased its position in shares of Colgate-Palmolive Company by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock valued at $110,000 after buying an additional 46 shares during the period. Bruderman Asset Management LLC increased its position in shares of Colgate-Palmolive Company by 0.3% in the third quarter. Bruderman Asset Management LLC now owns 1,556 shares of the company’s stock valued at $115,000 after buying an additional 4 shares during the period. Itau Unibanco Holding S.A. bought a new position in shares of Colgate-Palmolive Company during the third quarter valued at approximately $118,000. Finally, Concannon Wealth Management LLC increased its position in shares of Colgate-Palmolive Company by 33.8% in the third quarter. Concannon Wealth Management LLC now owns 1,605 shares of the company’s stock valued at $119,000 after buying an additional 405 shares during the period. Institutional investors own 71.67% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Analysts Set Colgate-Palmolive Company (CL) Price Target at $74.85” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright laws. The correct version of this piece of content can be accessed at http://www.dailypolitical.com/2017/01/14/analysts-set-colgate-palmolive-company-cl-price-target-at-74-85.html.

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.